redhot has signed a distribution agreement with Triolab Oy, Finland
January 20, 2022
redhot diagnostics have a new distributor in Finland, Triolab Oy Since 2018, have focused on mass spectrometry as an analysis method (LC-MS/MS).
Menu
with a focus on therapeutic drug monitoring
We produce, market and sell diagnostic products with innovative vision
Our products
Phosphatidylethanol (PEth)
Phosphatidylethanol (PEth) in the blood is a biomarker for alcohol consumption and is in the body an unnatural phospholipid that can only be formed in presence of alcohol, which theoretically provides 100% diagnostic specificity for alcohol.
Tamoxifen
Tamoxifen is widely prescribed for women with breast cancer and a 5- to 10-year treatment is recommended to prevent recurrence of the cancer. Tamoxifen is a prodrug, it must be metabolized in the body to be active; the primary active metabolites are z-endoxifen and 4-hydroxy tamoxifen. redhot diagnostics has developed a system for Therapeutic Dose Monitoring to help these women to get a correct dose of tamoxifen.
Methylmalonic Acid (MMA)
Elevated levels of Methylmalonic acid (MMA) are an indication of vitamin B12 deficiency. redhot has developed a new method for determination of methylmalonic acid that circumvents the problem with background from MMA in blank blood, using the HILIC separation technique. It is a very robust and sensitive method. The LC-MS/MS application is intended for the quantitative determination of Methylmalonic acid (MMA) in serum/plasma (whole blood), and is available as a prototype. Please contact us for more information.
rhelise™ kit
redhot diagnostics has developed a new blood sampling kit, rhelise ™ kit. The kit is intended to be used by a layperson to collect capillary whole blood for analysis of biomarkers and drug metabolites. The capillary takes typically 20 - 70 µL of blood. The kit is developed for PEth, Tamoxifen and Methylmalonic Acid (B-vitamin deficiency)
What our customers say
I’m a paragraph. Click here to add your own text and edit me. It’s easy. I’m a great place for you to tell a story.
Hannah Andersson
I’m a paragraph. Click here to add your own text and edit me. It’s easy. I’m a great place for you to tell a story and let your users see.
Johan Andersson
I’m a paragraph. Click here to add your own text and edit me. It’s easy. I’m a great place for you to tell a story and let your users see.
Hannah Andersson
I’m a paragraph. Click here to add your own text and edit me. It’s easy. I’m a great place for you to tell a story and let your users see.
0
Company was founded
0
Employees today
0
Years experience
0
Consumed coffee cups
Our company
redhot diagnostics AB is a company that offers state-of-the art diagnostic products to research and routine laboratories at hospitals. Using our patent-pending rhelise™ kit, we are enabling diagnostic testing and therapeutic drug monitoring of patients in their home environment.
Read Our News
Read More »
redhot diagnostics receives an Intention to Grant from the European Patent Office for the rhelise™ kit. Application no. PCT/EP2020/051233
October 12, 2021
redhot diagnostics AB (redhot) 20 July 2021 has received an Intention to Grant notice from the European Patent Office (“EPO”) for its
rhelise® kit for monitoring of pharmaceuticals levels in cancer patients
February 21, 2019
Redhot diagnostics has developed the rhelise® kit, that makes it possible to take a capillary sample from a lancet stick in the